Literature DB >> 2993645

Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.

A Seth, G F Vande Woude.   

Abstract

The nucleotide sequence of the Moloney murine sarcoma virus strain HT-1 (HT1MSV) mos gene differs from that of the cellular mos gene in three positions, but these are silent changes, and the amino acid sequence of the v-mos and c-mos open reading frames are identical. We have overproduced the mos HT1MSV (equivalent to c-mos) in Escherichia coli under the control of phage lambda promoter (pL). The E. coli p40mos protein thus obtained was partially purified and examined for several biochemical activities. We show that the p40mos binds ATP analog p-fluorosulfonylbenzoyladenosine and exhibits ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993645      PMCID: PMC252499     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Nucleotide sequence of the genome of a murine sarcoma virus.

Authors:  C Van Beveren; F van Straaten; J A Galleshaw; I M Verma
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

2.  Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome.

Authors:  E P Reddy; M J Smith; S A Aaronson
Journal:  Science       Date:  1981-10-23       Impact factor: 47.728

3.  Rous sarcoma virus transforming protein, p60src, expressed in E. coli, functions as a protein kinase.

Authors:  T M Gilmer; R L Erikson
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Analysis of transforming gene products from Moloney murine sarcoma virus.

Authors:  J Papkoff; M H Lai; T Hunter; I M Verma
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

5.  Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.

Authors:  F Sanger; A R Coulson; B G Barrell; A J Smith; B A Roe
Journal:  J Mol Biol       Date:  1980-10-25       Impact factor: 5.469

6.  Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase.

Authors:  W C Barker; M O Dayhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Identification of the catalytic subunit of casein kinase II by affinity labeling with 5'-p-fluorosulfonylbenzoyl adenosine.

Authors:  G M Hathaway; M J Zoller; J A Traugh
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

8.  Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus.

Authors:  C Van Beveren; J A Galleshaw; V Jonas; A J Berns; R F Doolittle; D J Donoghue; I M Verma
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

9.  Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells.

Authors:  S A Buhrow; S Cohen; J V Staros
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

10.  Expression of transforming region of Moloney murine sarcoma virus in Escherichia coli as a fusion protein with small tumor antigen of polyoma virus.

Authors:  D J Donoghue; T Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

View more
  22 in total

1.  Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.

Authors:  R S Freeman; D J Donoghue
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  Identification of the human papillomavirus E2 protein in genital tract tissues.

Authors:  C C Li; R V Gilden; S D Showalter; K V Shah
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.

Authors:  N Yew; M Oskarsson; I Daar; D G Blair; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

4.  v-mos protein produced by in vitro translation has protein kinase activity.

Authors:  N K Herzog; M Nash; L S Ramagli; R B Arlinghaus
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Nucleoside triphosphate-dependent DNA-binding properties of mos protein.

Authors:  A Seth; E Priel; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  A new recombinant DNA strategy for the molecular cloning of rare membrane proteins.

Authors:  B Brake; P Braghetta; G Banting; G Bressan; J P Luzio; K K Stanley
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

7.  Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.

Authors:  M Gonzatti-Haces; A Seth; M Park; T Copeland; S Oroszlan; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  Inhibition of v-Mos kinase activity by protein kinase A.

Authors:  Y Yang; C H Herrmann; R B Arlinghaus; B Singh
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

9.  Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells.

Authors:  J K Mayo; K E Sampson; L D Adams; E R Crumm; S L Kelly; I Abraham
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  A comparative endpoint study of lesions induced by MoMuSV-m1, MoMuSV-HT1, MoMuSV-124 and MoMuSV-349.

Authors:  R J Hoffman; G Stoica
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.